APOLLO HOSPITALS ENTER. L Fair Value
APOLLOHOSP · Healthcare · Current price ₹8,732
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹745 | 22% ROE fading to 13% over ~3 yrs, on ₹659 book |
| Relative P/E | ₹8,736 | EPS × 64.7 peer-median P/E |
| Graham floor | ₹1,415 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | ₹9,748 | Street consensus 12-month target price |
Is APOLLO HOSPITALS ENTER. L undervalued?
DocStoX estimates the fair value of APOLLO HOSPITALS ENTER. L at ₹4,291 per share, versus the current market price of ₹8,732. That puts the stock about -50.9% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹745), Relative P/E (₹8,736), Graham floor (₹1,415), Analyst target (₹9,748). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹745 (bear) to ₹4,291 (base) to ₹9,748 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on APOLLO HOSPITALS ENTER. L
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.